<DOC>
	<DOCNO>NCT00231192</DOCNO>
	<brief_summary>This study test hypothesis oral repaglinide equivalent insulin treatment new-onset CFRD adolescent . In addition , successful treatment CFRD repaglinide improve nutritional status , ameliorate decline pulmonary function , negative impact upon quality life .</brief_summary>
	<brief_title>Repaglinide Adolescents With Cystic Fibrosis-Related Diabetes</brief_title>
	<detailed_description>This study test hypothesis oral repaglinide equivalent insulin treatment new-onset CFRD . This hypothesis test use follow aim : Specific Aim 1 : To determine effect three month repaglinide insulin treatment upon blood glucose ( BG ) insulin excursion oral glucose tolerance test . Specific Aim 2 : To determine effect three month repaglinide insulin treatment upon BG measure continuous glucose monitoring , fast BG , 2-hour post-prandial BG , hemoglobin A1C , serum fructosamine . Secondary Aim 1 : To determine effect three month repaglinide insulin treatment upon weight , body mass index , lean body mass adolescents new-onset CFRD . Secondary Aim 2 : To determine effect three month repaglinide insulin treatment upon pulmonary function adolescent new-onset CFRD . Secondary Aim 3 : To determine effect three month repaglinide insulin treatment upon quality life new-onset CFRD .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Cystic Fibrosis , Blood glucose concern diabetes Known Cystic FibrosisRelated Diabetes , Liver Disease , FEV1 &lt; 40 %</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Insulin</keyword>
	<keyword>Repaglinide</keyword>
</DOC>